Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $106.7100 (-1.06%) ($105.4600 - $107.1400) on Wed. Mar. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.46% (three month average) | RSI | 61 | Latest Price | $106.7100(-1.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(36%) VYM(32%) XLP(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.73% in a week (0% probabilities). VIXM(-21%) UUP(-10%) VXX(-3%) TLT(-1%) KWEB(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.73% (StdDev 1.46%) | Hourly BBV | -1 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $107.61(-0.84%) | 10 Day Moving Average | $107.15(-0.41%) | 20 Day Moving Average | $106.54(0.16%) | To recent high | -5.2% | To recent low | 4.3% | Market Cap | $188.267b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |